L. Atahan Et Al. , "Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized study.," 48th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology , vol.66, Pennsylvania, United States Of America, 2006
Atahan, L. Et Al. 2006. Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized study.. 48th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology , (Pennsylvania, United States Of America).
Atahan, L., Yildiz, F., Cengiz, M., Kaplan, B., Ozkan, M., Haydaroglu, A., ... Sengoz, M.(2006). Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized study. . 48th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology, Pennsylvania, United States Of America
Atahan, L. Et Al. "Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized study.," 48th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology, Pennsylvania, United States Of America, 2006
Atahan, L. Et Al. "Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized study.." 48th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology , Pennsylvania, United States Of America, 2006
Atahan, L. Et Al. (2006) . "Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized study.." 48th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology , Pennsylvania, United States Of America.
@conferencepaper{conferencepaper, author={L. Atahan Et Al. }, title={Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized study.}, congress name={48th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology}, city={Pennsylvania}, country={United States Of America}, year={2006}}